Which statement by a client about levetiracetam indicates a need for further education?

The statement regarding driving after a few weeks on levetiracetam indicates a need for further education because it reflects a misunderstanding of the medication's effects on an individual's ability to operate a vehicle safely. Levetiracetam is an antiepileptic medication that can cause drowsiness, fatigue, and other neuropsychiatric effects, particularly when a patient first starts the treatment or if their dosage is increased.

While some patients may feel stable enough to resume driving after a period on the medication, it is essential for them to discuss this with their healthcare provider and ensure that they meet the criteria for safe driving, such as being seizure-free and not experiencing significant side effects like drowsiness or decreased concentration. The decision to drive should be individualized and monitored closely, especially in the initial stages of treatment.

Other statements, such as the need to report new anxiety or a rash, reflect an understanding of levetiracetam's potential side effects and the importance of monitoring for adverse reactions, which shows that the client is aware of the medication's risks.